Second, in this exploratory study, the stratification of patients into subjects with low and high inflammatory activity by means of the median CRP-level is somewhat arbitrary, and further studies aiming to define the range of inflammatory activity in RA or other inflammatory autoimmune diseases with an added value of sTfR measurement are required. The gene discussed is CRP; the disease is rheumatoid arthritis.